Aura Biosciences, Inc. AURA
6.00
(0.15)
(2.44%)
as of 25 Sep
- Market cap
- $637.8M
- P/E
- 0.0×
Follow AURA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (53.49%) | (95.57%) | (73.52%) | (64.26%) |
+8 more TTM periods Free account |
|
| (47.42%) | (76.70%) | (60.35%) | (53.86%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(42.04%) | (107.79%) | (79.26%) | (69.17%) | |
Free Cash Flow per Share |
(1.09) | (1.36) | (1.41) | (1.35) | |
Free Cash Flow |
(103.35) | (91.64) | (85.19) | (88.79) | |
Capital Expenditures |
(0.34) | (0.36) | (0.45) | (0.57) | |
| Other line items | |||||
Cash ROIC |
(16.12%) | (41.12%) | (30.14%) | (27.70%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.79 | 0.81 | 0.80 | 0.83 | |
Depreciation/Fixed assets |
0.49 | 0.45 | 0.43 | 0.44 | |
Capex/Depreciation |
(0.32) | (0.33) | (0.40) | (0.50) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.09) | (1.35) | (1.40) | (1.34) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates